Overview
Portal hypertensive gastropathy (PHG) is a condition characterized by vascular abnormalities in the stomach mucosa due to portal hypertension, leading to mucosal congestion, hemorrhage, and potential bleeding. 1Diagnosis
Clinical symptoms include upper gastrointestinal bleeding, anemia, and melena.
Biochemical evaluations may show alterations in liver function tests.
Imaging studies (e.g., endoscopy) are crucial for visualizing characteristic vascular changes in the gastric mucosa.
Endoscopic findings often include dilated, congested capillaries and venules without significant ulceration 1.Management
First-line treatments:
- Endoscopic interventions such as band ligation or sclerotherapy for acute bleeding episodes.
- Vasoconstrictors like somatostatin or octreotide to control bleeding (dose specifics not provided).
Adjunctive treatments:
- Beta-blockers to reduce portal pressure (specific dosing not detailed).
- Antacids or proton pump inhibitors to manage acid-related symptoms.
- In cases with biliary complications, short-term stent placement may help identify and manage ischemic strictures 1.Special Populations
Comorbidities: Management in patients with concomitant portal vein thrombosis or biliary strictures may require tailored approaches, such as stent trials to assess specific contributing factors 1.Key Recommendations
Consider a short-term stent trial in patients with portal hypertensive biliopathy to differentiate between various contributing factors like ischemic strictures versus other causes 1 (Evidence: Moderate).
Prioritize endoscopic interventions for acute bleeding episodes in portal hypertensive gastropathy 1 (Evidence: Moderate).
Use vasoconstrictors like octreotide for controlling acute bleeding, though specific dosing should be guided by clinical judgment 1 (Evidence: Moderate).References
1 Cantù P, Bezzio C. Role of a short-term stent-trial in a patient with biliary stricture and portal hypertensive biliopathy: long-term outcome result. Digestive diseases and sciences 2011. link